CoChat

A Prospective Clinical Trial of D–Penicillamine in the Treatment of Primary Biliary Cirrhosis

Bodenheimer, Henry C., Schaffner, Fenton, Sternlieb, Irmin, Klion, Franklin M., Vernace, Salvatore, Pezzullo, John · 1985 · Hepatology
Cited by 60

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

We conducted a prospective clinical trial to assess the relative efficacy and safety of high– vs. low–dose D–penicillamine in patients with primary biliary cirrhosis. Following clinical tests and liver biopsy diagnostic of primary biliary cirrhosis, 56 patients were randomized to receive either 250 or 750 mg D–penicillamine daily. Patients were monitored with clinical tests and annual liver biopsy. Randomization produced two groups without differences in demographic, clinical or histologic characteristics. During the trial, no differences were seen between the mean change in liver test results in patients in either treatment group. The 11% per year rise of bilirubin in the 750 mg dose group during the first 3 years was not significantly different from the 18% per year rise in the 250 mg dose group. No patient showed improvement on liver biopsy although patients on 750 mg D–penicillamine deteriorated more slowly. Side effects, particularly rash and dysgeusia, were more common in the 750 mg dose group. The frequency and severity of side effects were responsible for the early conclusion of our trial. Twenty–six patients experienced side effects necessitating discontinuation of D–penicillamine. No evidence of increased efficacy was demonstrated by high–dose D–penicillamine therapy, and side effects were observed in patients on 250 mg D–penicillamine daily. With the severity of adverse effects and continued progression of disease, D–penicillamine is not a clinically useful therapy in primary biliary cirrhosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.1840050613

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 60

Metadata

Authors
Bodenheimer, H. C., Schaffner, F., Sternlieb, I., Klion, F. M., Vernace, S., & Pezzullo, J.
Venue
Hepatology
Published
1985-11
Volume
5
Issue
6
Pages
1139-1142
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2009221394
Cited by
60
References
1
FWCI
2.87
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Prospective Clinical Trial of D–Penicillamine in the Treatment of Primary Biliary Cirrhosis. https://app.cochat.ai/papers/10.1002/hep.1840050613
The paper
Bodenheimer, H. C., Schaffner, F., Sternlieb, I., Klion, F. M., Vernace, S., & Pezzullo, J. (1985). A Prospective Clinical Trial of D–Penicillamine in the Treatment of Primary Biliary Cirrhosis. Hepatology. https://doi.org/10.1002/hep.1840050613

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.